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The Editorial on the Research Topic
Role of HLA and KIR in Viral Infections
The immune system continuously protects its host against pathogens. During viral infections, both 
innate and adaptive immune cells contribute to an effective immune response. Natural killer (NK) 
cells can respond quickly to eliminate pathogens and infected cells and suppress dissemination to 
other tissues. Subsequently, activation of virus-specific CD8+ cytotoxic T cells results in specific 
killing of infected cells and activation of virus-specific CD4+ T cells further supports the immune 
response. Human leukocyte antigens (HLA) play an essential role in activation of both NK cells and 
T cells. This research topic contains eight articles highlighting the latest insights into the various 
effects of HLA molecules on both NK cell and T-cell reactivity upon viral infection.
Natural Killer cell activation is regulated by a variety of activating and inhibitory receptors, 
including killer-cell immunoglobulin-like receptors (KIRs). KIRs bind to HLA class I molecules, 
which are expressed on all nucleated cells. As HLA and KIR molecules are highly polymorphic, 
each individual expresses a unique set of these molecules. The wide range of combinations of HLA 
and KIR expression results in differences in binding strengths and variation in NK cell activation 
(1). In this research topic, a review by Walter and Ansari illuminates the associations of HLA and 
KIR polymorphisms with the outcome of experimental simian immunodeficiency virus infection in 
rhesus macaques, a model used to study human immunodeficiency virus (HIV) infection. Not only 
do these associations show which interactions contribute to disease resistance, they also pinpoint 
combinations that increase susceptibility to disease. Such associations of HLA and KIR with disease 
progression have also been found in hepatitis C virus (HCV) infection. In her review, Gardiner 
summarizes current insights into these associations, and further illustrates how NK cells modulate 
disease outcome in HCV infection. Furthermore, this review highlights the ongoing search for the 
NK cell subsets required for protective host responses.
In addition to KIRs, NK cells express C-type lectin receptors, including NKG2C, which regulate 
activation via ligation to non-classical HLA-E molecules. Della Chiesa et al. summarize the role of 
activating KIRs and NKG2C in several virus infections, including human cytomegalovirus (HCMV) 
and HIV. In addition, they discuss the induction of memory-like NK cells, which show enhanced 
responses upon reinfection and may play a role in controlling recurrent or chronic infections. 
Expression of NKG2C has also been associated with expansion of NK cells during viral infection. 
This expansion of NKG2C+ NK cells with expression of self-HLA class I-specific KIRs has been 
observed in HCMV infection (2). The force driving these NK cell expansions is largely unclear. In 
this collection, Beziat et al. investigate the importance of HLA class I expression levels in host defense 
using data derived from transporter associated with antigen processing (TAP)-deficient individuals 
who express less than 10% of normal HLA class I levels. They demonstrate that self-HLA class I 
molecules shape the KIR repertoire of NKG2C+ NK cells, but are not a requirement for expansion.
Besides influencing innate NK responses via ligation to KIRs, HLA induces adaptive immune 
responses by presenting pathogen-derived peptides to T cells. Recognition of HLA:peptide complexes 
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by a peptide-specific T-cell receptor leads to  activation of specific 
CD8+ cytotoxic T cells or CD4+ T helper cells. In HCMV infec-
tion, effective CD8+ T-cell responses have been shown to be 
dominated by peptides derived from immediate-early 1 (IE-1) 
protein (3–5). Whether IE-1 is also the dominant peptide source 
for CMV-specific CD4+ T cell responses is unclear. Using cells 
derived from healthy HCMV-positive donors, Ameres et  al. 
generated multiple IE-1-specific CD4+ T cell clones with a highly 
diverse repertoire and found that IE-1-specific CD4+ T  cells 
participate in the antiviral response. Since both CD4+ and CD8+ 
T cells respond to IE-1-derived peptides, it might be an interest-
ing target for immunotherapeutic approaches.
Infection with measles virus is known to induce a strong T cell 
response (6, 7), but information regarding the specific measles 
virus antigens that are responsible for activation of these cells is 
limited. Schellens et al. investigated which measles peptides are 
presented by HLA class I molecules by eluting naturally presented 
peptides from virus-infected cells. They show that a broad spec-
trum of the measles peptidome is presented by different HLA 
class I molecules. Furthermore, they found that while HLA-B 
molecules present the most diverse set of peptides, the abundant 
epitopes were eluted from HLA-A and HLA-C molecules, sug-
gesting that the HLA loci also influence peptide presentation.
Due to the polymorphic nature of HLA molecules, a great 
diversity of peptides are typically presented, resulting in T-cell 
activation of variable strengths. In HCV infections, some HLA 
molecules (e.g., HLA-B27 and HLA-B57) are significantly asso-
ciated with viral clearance (8, 9). However, it is not yet known 
why such HLA molecules provide an advantage during HCV 
infections. Using known HCV epitopes combined with in silico 
predictions, Rao et al. demonstrate that HLA-B27 preferentially 
presents epitopes from the HCV protein NS5B, which is highly 
conserved and, therefore, might be one of the underlying 
 mechanisms behind the protective effect of this molecule during 
HCV infection. Preferential presentation of peptides derived from 
conserved regions was also found for HIV (10–12). However, the 
induction of effective immune responses also puts pressure on the 
virus to adapt toward escape variants. The generation of escape 
variants often comes with significant costs, such as reduced viral 
replicative capacity. In the final paper of this issue, a review by 
KlØverpris et  al. illustrates the effects of viral escape variants 
within the HIV-infected patient as well as the consequences of 
transmission of these variants at the population level.
Together, the research and reviews in this research topic 
provide an up-to-date overview of the importance of HLA and 
KIR molecules in host responses to viral infection. Given the 
central role of HLA in modulating both innate and adaptive 
immune responses, it is important to expand our knowledge on 
the role of different HLA molecules in various diseases. A better 
understanding of the differences between the individual immune 
responses, especially when it fails to protect against pathogens, 
should ultimately help to develop better  –  and possibly more 
individualized – treatment options.
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